BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36747329)

  • 1. Disparities among Japanese municipalities in recommendations for routine and catch-up HPV vaccinations.
    Watanabe Y; Ueda Y; Yagi A; Ikeda S; Oka E; Kakuda M; Nakagawa S; Hiramatsu K; Miyoshi A; Kobayashi E; Kimura T; Kimura T
    Cancer Sci; 2023 May; 114(5):2139-2144. PubMed ID: 36747329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intentions for catch-up HPV vaccination in Japan: an internet survey.
    Nakagawa S; Yagi A; Ueda Y; Ikeda S; Kakuda M; Hiramatsu K; Miyoshi A; Kimura T; Hirai K; Sekine M; Nakayama T; Kobayashi E; Miyagi E; Enomoto T; Kimura T
    Int J Clin Oncol; 2023 Dec; 28(12):1667-1679. PubMed ID: 37776388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
    Cody P; Tobe K; Abe M; Elbasha EH
    BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of HPV vaccination rates in Japan: the effect of individual notifications implemented by local governments.
    Yagi A; Ueda Y; Nakagawa S; Ikeda S; Kakuda M; Hiramatsu K; Miyoshi A; Kobayashi E; Kimura T; Hirai K; Nakayama T; Miyagi E; Sekine M; Enomoto T; Kimura T
    Int J Clin Oncol; 2022 Oct; 27(10):1651-1659. PubMed ID: 35879494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of HPV vaccine hesitancy among catch-up generations in Japan: A descriptive study.
    Machida M; Inoue S
    Vaccine; 2023 May; 41(18):2956-2960. PubMed ID: 37024410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation.
    Ishimoto T; Yagi A; Nakajima K; Okamoto N; Yukimitsu E; Kawasaki M; Kawae Y; Hayasaka S; Ueda Y; Kimura T
    Hum Vaccin Immunother; 2023 Aug; 19(2):2229222. PubMed ID: 37462048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.
    Castellsagué X; Schneider A; Kaufmann AM; Bosch FX
    Gynecol Oncol; 2009 Dec; 115(3 Suppl):S15-23. PubMed ID: 19819540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women.
    Onuki M; Yamamoto K; Yahata H; Kanao H; Yokota H; Kato H; Shimamoto K; Takehara K; Kamiura S; Tsuda N; Takei Y; Shigeta S; Matsumura N; Yoshida H; Motohara T; Watari H; Nakamura K; Ueda A; Tasaka N; Ishikawa M; Hirashima Y; Kudaka W; Taguchi A; Iwata T; Takahashi F; Kukimoto I; Yoshikawa H; Yaegashi N; Matsumoto K;
    Cancer Sci; 2022 Apr; 113(4):1428-1434. PubMed ID: 35043515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
    Gertig DM; Brotherton JM; Budd AC; Drennan K; Chappell G; Saville AM
    BMC Med; 2013 Oct; 11():227. PubMed ID: 24148310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0,12 month schedule among 10 to 14 year old girls.
    LaMontagne DS; Manangazira P; Marembo J; Chigodo C; Zvamashakwe C; Tshuma E; Marima E; Chindedza K; Ndlela E; Mooney J
    Vaccine; 2022 Mar; 40 Suppl 1():A58-A66. PubMed ID: 34275674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compensation programs after withdrawal of the recommendation for HPV vaccine in Japan.
    Yuji K; Nakada H
    Hum Vaccin Immunother; 2016 May; 12(5):1321-4. PubMed ID: 26513303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan.
    Yagi A; Ueda Y; Nakagawa S; Masuda T; Miyatake T; Ikeda S; Abe H; Hirai K; Sekine M; Miyagi E; Enomoto T; Nakayama T; Kimura T
    Cancer Sci; 2021 Sep; 112(9):3691-3698. PubMed ID: 34252250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007.
    Kramer MR; Dunlop AL
    Matern Child Health J; 2012 Apr; 16 Suppl 1():S102-10. PubMed ID: 22453332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of social norms for uptake of catch-up human papillomavirus vaccination in young women.
    de Visser R; Waites L; Parikh C; Lawrie A
    Sex Health; 2011 Sep; 8(3):330-7. PubMed ID: 21851772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV Vaccinations in Lublin Region, Poland.
    Kalinowski P; Grządziel A
    Postepy Hig Med Dosw (Online); 2017 Feb; 71(0):92-97. PubMed ID: 28258669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia.
    Regan DG; Philp DJ; Hocking JS; Law MG
    Sex Health; 2007 Sep; 4(3):147-63. PubMed ID: 17931528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of catch-up in vaccination against human papillomavirus in medium- and low-income countries.
    Baussano I; Lazzarato F; Ronco G; Dillner J; Franceschi S
    Int J Cancer; 2013 Oct; 133(8):1876-81. PubMed ID: 23564420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study.
    Simms KT; Hanley SJB; Smith MA; Keane A; Canfell K
    Lancet Public Health; 2020 Apr; 5(4):e223-e234. PubMed ID: 32057317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.